Exhaled Carbon Monoxide and Risk of Metabolic Syndrome and Cardiovascular Disease in the Community
- 12 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 122 (15) , 1470-1477
Abstract
Background—: Endogenous carbon monoxide (CO) at physiological concentrations is cytoprotective, whereas excess levels reflect underlying oxidative stress, inflammation, and vascular pathology and portend adverse clinical sequelae. However, the relation of exhaled CO to metabolic/vascular risk in the community is unknown. Methods and Results—: We related exhaled CO, a surrogate measure of blood CO concentration, to the risk of developing new-onset metabolic syndrome and incident cardiovascular disease following 14 943 routine examinations (4139 unique participants; mean age, 46 years, 53% women) in the Framingham Heart Study. Baseline exhaled CO was associated with the presence of cardiometabolic risk factors (including smoking) and prevalent metabolic syndrome (odds ratio, 1.09 per log CO; 95% confidence interval, 1.02 to 1.17; P =0.01). During up to 4 years of follow-up, 1458 participants developed new-onset metabolic syndrome, and 416 experienced a first cardiovascular disease event. Compared with individuals in the lowest quartile of exhaled CO, those in the highest quartile were more likely to develop metabolic syndrome (odds ratio, 1.48; 95% confidence interval, 1.25 to 1.76; P P =0.008) in multivariable analyses that included adjustment for smoking status. Conclusion—: In our community-based sample, higher exhaled CO levels predicted the development of metabolic syndrome and future cardiovascular disease events, underscoring the importance of this endogenous second messenger in the pathogenesis of metabolic and vascular risk.Keywords
This publication has 39 references indexed in Scilit:
- Dual Pathways of Carbon Monoxide–Mediated VasoregulationCirculation Research, 2009
- Bench-to-bedside review: Carbon monoxide – from mitochondrial poisoning to therapeutic useCritical Care, 2009
- Genome-wide association with select biomarker traits in the Framingham Heart StudyBMC Medical Genetics, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Heterogeneity of cardiovascular risk among smokers is related to degree of carbon monoxide exposureAtherosclerosis, 2005
- Increased Carbon Monoxide in Exhaled Air of Critically Ill PatientsBiochemical and Biophysical Research Communications, 2000
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- Relation of pooled logistic regression to time dependent cox regression analysis: The framingham heart studyStatistics in Medicine, 1990
- Effects of age and sex on microsomal heme oxygenase and cytochrome P-450 content in liver of rats.Journal of Pharmacobio-Dynamics, 1981
- Endogenous Carbon Monoxide Production and Body CO StoresActa Medica Scandinavica, 1967